PMID: 30142727Aug 26, 2018Paper

Corrigendum: Leukemia cutis as the presenting symptom of acute myeloid leukemia: report of three cases

Dermatology Online Journal
Amanda B MoyerJerad M Gardner

Abstract

The original article was published on July19, 2017 and corrected on June 15, 2018.The revised version of the article adds appropriate in-text references to Figures 3B, C and 5B, C, and correctly renumbers the list of References. The changes appear in the revised online PDF copy of this article.

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

Journal of Drugs in Dermatology : JDD
Tatyana BabinaBrian Thomas
Archivos argentinos de pediatría
Noelia M GómezGabriela Gea Sánchez
Cleveland Clinic Journal of Medicine
Christos Tziotzios, Areti Makrygeorgou
Deutsches Ärzteblatt International
Joachim Dissemond, Elvir Cesko
Internal Medicine
Isao MiyoshiHirokuni Taguchi
© 2022 Meta ULC. All rights reserved